Alembic Pharmaceuticals successfully completes USFDA inspection at Baroda facility

17 Apr 2017 Evaluate

Alembic Pharmaceuticals’ Bioequivalence facility located at Baroda was successfully inspected by US Food & Drug Administration (USFDA) between March 06, 2017 & March 10, 2017, between March 13, 2017 and March 17, 2017 and between April 10, 2017 to April 12, 2017 for Bioequivalence Clinical, Bioequivalence Bioanalytical and Pharmacovigilance. There were no 483s issued by USFDA at the end of the inspection. 

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

699.05 -7.75 (-1.10%)
12-Mar-2026 10:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1822.05
Dr. Reddys Lab 1316.75
Cipla 1333.55
Zydus Lifesciences 919.00
Lupin 2318.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×